Related stories
Amgen Reports Positive Phase 3 Results for Dazodalibep
Amgen announced positive Phase 3 results for dazodalibep in Sjögren's disease.
M impact | EQUITY | Nov 11, 2026, 02:26 PM UTC
Summa Defence Subsidiary Summa Energy Files for Bankruptcy
Summa Defence said its subsidiary Summa Energy Oy has filed for bankruptcy.
L impact | EQUITY | Nov 11, 2026, 02:15 PM UTC
Anthropic Begins Proposed IPO Roadshow at $70–$78 Per Share
Anthropic launched its IPO roadshow and filed Amendment No. 2 to its S-1. The proposed offering is 825.0 million shares; the registration statement has not become effective.
M impact | EQUITY | Nov 11, 2026, 02:10 PM UTC
Cable One Warns It May File for Bankruptcy Without New Financing
Cable One said it may need to file for bankruptcy if it cannot complete financing to repay debt maturing in 2028 and MBI loans due next year. A federal court temporarily blocked it
M impact | EQUITY | Nov 11, 2026, 02:05 PM UTC
Mercer International Begins Prepackaged Chapter 11 Restructuring
The company began a U.S. bankruptcy-court process to execute a previously announced recapitalization. The plan would reduce senior note debt by approximately 88%, eliminate over $1
M impact | EQUITY | Nov 11, 2026, 02:05 PM UTC
Brazil auto sales fell in October from September
L impact | EQUITY | Nov 11, 2026, 02:04 PM UTC